Archive

What thyroid hormones actually regulate, why standard TSH screening misses the conversion problem that subclinical hypothyroidism most commonly involves, how reverse T3 explains unexplained metabolic slowdown, and why addressing thyroid function is the foundation every other optimization protocol depends on.

What GHK-Cu is, why its 60 percent decline between age 20 and 60 matters, how its gene expression modulation of over 4,000 human genes explains effects that no single receptor mechanism could produce, and where injectable, oral, and topical delivery forms serve different application purposes in a comprehensive protocol.

What insulin resistance actually is, why normal glucose measurements miss it for years while it drives visceral fat, cardiovascular disease, hormonal dysfunction, and cognitive decline, and how the optimization toolkit addresses the upstream metabolic dysfunction rather than its downstream manifestations.

What kisspeptin's role in the LH surge actually is, how KNDy neuron hyperactivity connects kisspeptin to hot flashes and sleep disruption in perimenopause, what the clinical research on kisspeptin and hypothalamic amenorrhea shows, and how it fits into a comprehensive female hormone optimization protocol.

The mechanistic logic behind why BPC-157 and TB-500 work better together than either alone, what KPV and GHK-Cu add to the Wolverine base, how the DSIP/BPC-157/CJC-1295 overnight stack uses temporal synergy, and the principle of complementarity that determines when a combination is genuinely superior to its individual components.